These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 21565138

  • 1. [Effects of chemotherapy combined with Chinese herbal medicine Kangliu Zengxiao decoction on tumor markers of patients with advanced non-small-cell lung cancer: a randomized, controlled trial].
    Yan GY, Xu ZY, Deng HB, Wan ZY, Zhang L, Zhu JY.
    Zhong Xi Yi Jie He Xue Bao; 2011 May; 9(5):525-30. PubMed ID: 21565138
    [Abstract] [Full Text] [Related]

  • 2. [Clinical study on treatment of advanced non-small cell lung cancer with kangliu zengxiao decoction].
    Wu J, Xu ZY, Wang ZQ.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Feb; 30(2):137-40. PubMed ID: 20462038
    [Abstract] [Full Text] [Related]

  • 3. [Clinical study on treatment of advanced non-small-cell lung cancer with Chinese herbal medicine in different stages combined with chemotherapy].
    Xu ZY, Jin CJ, Shen DY.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Oct; 27(10):874-8. PubMed ID: 17990450
    [Abstract] [Full Text] [Related]

  • 4. Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy.
    Xu ZY, Jin CJ, Zhou CC, Wang ZQ, Zhou WD, Deng HB, Zhang M, Su W, Cai XY.
    J Cancer Res Clin Oncol; 2011 Jul; 137(7):1117-22. PubMed ID: 21298288
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of Aidi Injection () on overexpression of P-glycoprotein induced by vinorelbine and cisplatin regimen in patients with non-small cell lung cancer.
    Ma JJ, Liu HP.
    Chin J Integr Med; 2017 Jul; 23(7):504-509. PubMed ID: 27484766
    [Abstract] [Full Text] [Related]

  • 6. The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer.
    Zhao T, Mao G, Chen M.
    Comput Math Methods Med; 2021 Jul; 2021():1951364. PubMed ID: 34603482
    [Abstract] [Full Text] [Related]

  • 7. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients.
    Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, Vanni I, Boccardo S, Rijavec E, Genova C, Biello F, Barletta G, Rossi G, Tagliamento M, Maggioni C, Grossi F.
    J Transl Med; 2019 Mar 08; 17(1):74. PubMed ID: 30849967
    [Abstract] [Full Text] [Related]

  • 8. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
    Jiang AG, Chen HL, Lu HY.
    BMC Cancer; 2015 May 10; 15():386. PubMed ID: 25956656
    [Abstract] [Full Text] [Related]

  • 9. Fuzheng Kang'ai decoction combined with gefitinib in advanced non-small cell lung cancer patients with epidermal growth factor receptor mutations: study protocol for a randomized controlled trial.
    Yang XB, Wu WY, Long SQ, Deng H, Pan ZQ, He WF, Zhou YS, Liao GY, Li QP, Xiao SJ, Cai JZ.
    Trials; 2015 Apr 10; 16():146. PubMed ID: 25873045
    [Abstract] [Full Text] [Related]

  • 10. [Clinical value of CEA and CYFRA21-1 as an assessment indicator of therapeutic efficacy in advanced non-small cell lung cancer patients].
    Li L, Song LH, Ding SC, Zhang XJ, Qiang L, Han CY, Yuan XT, Xu DD.
    Zhonghua Zhong Liu Za Zhi; 2010 Nov 10; 32(11):850-4. PubMed ID: 21223692
    [Abstract] [Full Text] [Related]

  • 11. [Enhancing effect of compound Kusheng injection in combination with chemotherapy for patients with advanced non-small cell lung cancer].
    Fan CX, Lin CL, Liang L, Zhao YY, Liu J, Cui J, Yang QM, Wang YL, Zhang AR.
    Zhonghua Zhong Liu Za Zhi; 2010 Apr 10; 32(4):294-7. PubMed ID: 20510083
    [Abstract] [Full Text] [Related]

  • 12. [Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage IIIB/IV non-small-cell lung cancer: a randomized controlled trial].
    Deng SQ, Ouyang XN, Yu ZY, Dai XH, Chen X, Fang FZ, Wang WW, Liu ZZ.
    Zhong Xi Yi Jie He Xue Bao; 2012 Jun 10; 10(6):635-40. PubMed ID: 22704411
    [Abstract] [Full Text] [Related]

  • 13. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors.
    Zhang Z, Yuan F, Chen R, Li Y, Ma J, Yan X, Wang L, Zhang F, Tao H, Guo D, Huang Z, Zhang S, Li X, Zhi X, Ge X, Hu Y, Wang J.
    Front Immunol; 2020 Jun 10; 11():1173. PubMed ID: 32587591
    [Abstract] [Full Text] [Related]

  • 14. A randomized controlled pilot trial of "Feiji Recipe" on quality of life of non-small cell lung cancer patients.
    Tian JH, Liu LS, Shi ZM, Zhou ZY, Wang L.
    Am J Chin Med; 2010 Jun 10; 38(1):15-25. PubMed ID: 20128041
    [Abstract] [Full Text] [Related]

  • 15. [Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial].
    Zhang ZY, Yu SQ, Miao LY, Huang XY, Zhang XP, Zhu YP, Xia XH, Li DQ.
    Zhong Xi Yi Jie He Xue Bao; 2008 Feb 10; 6(2):134-8. PubMed ID: 18241646
    [Abstract] [Full Text] [Related]

  • 16. Clinical Evaluation of Tumor Markers for Diagnosis in Patients with Non-small Cell Lung Cancer in China.
    Ma L, Xie XW, Wang HY, Ma LY, Wen ZG.
    Asian Pac J Cancer Prev; 2015 Feb 10; 16(12):4891-4. PubMed ID: 26163610
    [Abstract] [Full Text] [Related]

  • 17. [Efficacy and adverse effets of nimotuzumab plus palitaxel liposome and carboplatin in the treatment for advanced non-small cell lung cancer].
    Qi DL, Wang HQ, Li Y, Huang CB, Wang QS, Xu L, Yang YZ, Cui Y, Xin L.
    Zhonghua Zhong Liu Za Zhi; 2012 Feb 10; 34(2):152-5. PubMed ID: 22780937
    [Abstract] [Full Text] [Related]

  • 18. [Randomized study of thalidomide combined with vinorelbine and cisplatin chemotherapy for the treatment of advanced non-small cell lung cancer].
    Gu AQ, Han BH, Zhang XY, Shen J, Qi DJ, Xiong LW, Xin Y, Song YY.
    Zhonghua Zhong Liu Za Zhi; 2009 Apr 10; 31(4):298-301. PubMed ID: 19615288
    [Abstract] [Full Text] [Related]

  • 19. [Treatment of Radical Resected NSCLC by Chinese Medicine Combined with Adjuvant Chemother- apy: a Clinical Study].
    Hou WX, Li HG, Chen ZW, Zhu LH, Zhao LH, Tian JH, Xu WJ, Zhou L, Yao YL.
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jun 10; 35(6):648-53. PubMed ID: 26242112
    [Abstract] [Full Text] [Related]

  • 20. Clinical efficacy and safety of aidi injection combination with vinorelbine and cisplatin for advanced non-small-cell lung carcinoma: A systematic review and meta-analysis of 54 randomized controlled trials.
    Xiao Z, Jiang Y, Wang CQ, Hu SS, Huang XR, Chen XF, Huang J, Shan LJ, Tang YH, Wang YH, Gong QH, Feng JH, Xiao X, Li XF.
    Pharmacol Res; 2020 Mar 10; 153():104637. PubMed ID: 31935454
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.